|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 48, 2275-2282, October 2007
Copyright © 2007 by American Society for Biochemistry and Molecular Biology
,
,**

,
,
* Departament de Genètica, Universitat de Barcelona, Barcelona, Spain
Centero de Investigación Biomédica en red de Enfermedades Raras, Barcelona Spain
Institut de Biomedicina de la Universitat de Barcelona, Barcelona Spain
** Institut de Bioquímica Clínica, Hospital Clínic, Corporació Sanitària Clínic, Barcelona, Spain

Research Institute, Hospital of Sick Children, Toronto, Canada
Published, JLR Papers in Press, July 30, 2007.
1 D. Grinberg and L. Vilageliu are co-last authors.
2 To whom correspondence should be addressed. e-mail: lvilageliu{at}ub.edu
GM1-gangliosidosis and Morquio B disease are lysosomal storage disorders caused by ß-galactosidase deficiency attributable to mutations in the GLB1 gene. On reaching the endosomal-lysosomal compartment, the ß-galactosidase protein associates with the protective protein/cathepsin A (PPCA) and neuraminidase proteins to form the lysosomal multienzyme complex (LMC). The correct interaction of these proteins in the complex is essential for their activity. More than 100 mutations have been described in GM1-gangliosidosis and Morquio B patients, but few have been further characterized. We expressed 12 mutations suspected to be pathogenic, one known polymorphic change (p.S532G), and a variant described as either a pathogenic or a polymorphic change (p.R521C). Ten of them had not been expressed before. The expression analysis confirmed the pathogenicity of the 12 mutations, whereas the relatively high activity of p.S532G is consistent with its definition as a polymorphism. The results for p.R521C suggest that this change is a low-penetrant disease-causing allele. Furthermore, the effect of these ß-galactosidase changes on the LMC was also studied by coimmunoprecipitations and Western blotting. The alteration of neuraminidase and PPCA patterns in several of the Western blotting analyses performed on patient protein extracts indicated that the LMC is affected in at least some GM1-gangliosidosis and Morquio B patients.
Supplementary key words ß-galactosidase heterologous expression lysosomal multienzyme complex
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |